Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGA4 | P13612 | 2/20 | 0.33 |
| ▸ | ITGB7 | P26010 | 2/20 | 0.33 |
| ▸ | AKT1 | P31749 | 1/20 | 0.32 |
| ▸ | KCNT1 | Q5JUK3 | 1/20 | 0.31 |
| ▸ | BRD4 | O60885 | 1/20 | 0.31 |
| ▸ | CTSS | P25774 | 3/20 | 0.30 |
| ▸ | CTSK | P43235 | 3/20 | 0.30 |
| ▸ | SCN9A | Q15858 | 3/20 | 0.30 |
| ▸ | CTSB | P07858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31752087 | 0.87 | AKT1 (0.33) | ITGA4ITGB7AKT1KCNT1CTSS | |
| Trifluoroacetic Acid SCHEMBL33525935 | 0.86 | LOXL2 (0.31) | KCNT1 | |
| SCHEMBL34466727 | 0.83 | ITGA4 (0.33) | ITGA4ITGB7AKT1KCNT1CTSS | |
| SCHEMBL34466946 | 0.83 | CTSL (0.36) | ITGA4ITGB7AKT1KCNT1CTSS | |
| SCHEMBL31752402 | 0.82 | CTSS (0.37) | ITGA4ITGB7AKT1CTSSCTSK | |
| SCHEMBL33526439 | 0.82 | PTGS2 (0.34) | BRD4 | |
| SCHEMBL31753528 | 0.82 | CTSS (0.32) | ITGA4ITGB7AKT1CTSSCTSK | |
| SCHEMBL34467066 | 0.82 | BCL2 (0.32) | ITGA4ITGB7AKT1CTSSCTSK | |
| SCHEMBL34466764 | 0.82 | CTSS (0.33) | ITGA4ITGB7AKT1CTSSCTSK | |
| SCHEMBL31753247 | 0.81 | CTSS (0.36) | ITGA4ITGB7AKT1CTSSCTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260091048-A1 | GIP RECEPTOR AGONIST COMPOUNDS | LILLY CO ELI (US) | 2026-04-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260091048-A1 | GIP RECEPTOR AGONIST COMPOUNDS | GIPR, GLP1R, GPR119 | ITGA4 1929/4885ITGB7 1595/4885AKT1 3218/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.